We are live on
!
Find out more
Novartis
NVS
NVS
763 hedge funds and large institutions have $17B invested in Novartis in 2013 Q2 according to their latest regulatory filings, with 763 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
66% more call options, than puts
Call options by funds: $95M | Put options by funds: $57.2M
9.93% more ownership
Funds ownership: 0% → 9.93% (+9.9%)
Holders
763
Holders Change
+763
Holders Change %
–
% of All Funds
24.81%
Holding in Top 10
54
Holding in Top 10 Change
+54
Holding in Top 10 Change %
% of All Funds
1.76%
New
763
Increased
–
Reduced
–
Closed
–
Calls
$95M
Puts
$57.2M
Net Calls
+$37.8M
Net Calls Change
+$37.8M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
NVS Hedge Fund Activity: Q2 2013 in Review
763 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q2 2013, worth a combined $17B.
Buyers outnumbered sellers: 763 funds opened new NVS positions and 0 closed out — a net gain of 763 holders — while 0 added to existing stakes and 0 trimmed.
- 763 institutional investors held Novartis (NVS) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $17B of Novartis stock for Q2 2013.
- 763 funds opened new Novartis positions in Q2 2013 and 0 closed out, a net change of +763 holders.
Based on aggregated 13F filings for Q2 2013.